Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Intelligence coverage: 55%
Basic profile, financials, and market data are shown below. Deep research is building in the background.
AI confidence 70% · prior close shown (market closed)
Limited proprietary earnings coverage for IMMX yet — signals will sharpen as filings and earnings are ingested.
Pipeline evidence · 29d ago
Updated
What happened recently for Immix Biopharma, Inc. (IMMX) — events, not interpretation.
Research & analysis only — not investment advice.
Investment snapshot
Prior close
$10.97
Market cap
$784.79M
Profitable
No
Revenue $20.00M
Net income
$-29.44M
FY Dec 8, 2022
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
US equity research on AlphaOS
Investment Snapshot above is the primary AlphaOS analysis for Immix Biopharma, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Connected companies and research pages from the AlphaOS knowledge graph.
Follow Immix Biopharma, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.